| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute |
NCT04564716: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus |
|
|
| Active, not recruiting | 3 | 100 | RoW | Gam-COVID-Vac, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, RDIF (Russian Direct Investment Fund), CRO: iPharma | Covid19 | 03/21 | 04/21 | | |
RESIST, NCT04530396: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 |
|
|
| Active, not recruiting | 3 | 33758 | RoW | Gam-COVID-Vac, placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Government of the city of Moscow, CRO: Crocus Medical BV | Covid19 Prevention | 05/21 | 05/21 | | |
SPUTNIK-UAE, NCT04656613: A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE |
|
|
| Not yet recruiting | 3 | 1000 | NA | Gam-COVID-Vac, Sputnik V, placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, PDC-CRO | Covid19, SARS-CoV Infection | 08/21 | 12/21 | | |
VENEZUELA, NCT04642339: Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela |
|
|
| Not yet recruiting | 3 | 2000 | NA | Gam-COVID-Vac, Sputnik V, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela | Covid19 | 10/21 | 12/21 | | |
NCT06068569: Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers |
|
|
| Not yet recruiting | 3 | 50 | NA | GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | COVID-19 | 12/24 | 12/24 | | |
NCT06068556: Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition) |
|
|
| Not yet recruiting | 3 | 50 | NA | GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | COVID-19 | 12/24 | 12/24 | | |
NCT04640233: Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection |
|
|
| Active, not recruiting | 2/3 | 1600 | RoW | Gam-COVID-Vac, Placebo | Dr. Reddy's Laboratories Limited, Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Russian Direct Investment Fund, CRO: JSS Medical Research India Pvt. Ltd. | COVID-19 Prevention | 08/21 | 09/21 | | |
| Recruiting | 2/3 | 3000 | RoW | Gam-COVID-vac M, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Moscow Healthcare Department | Covid19, Vaccine Preventable Disease | 11/22 | 12/23 | | |
